Workflow
Stratasys(SSYS) - 2024 Q4 - Annual Report

Financial Support and Taxation - The company has received approximately 9 million in grants from the Israeli Innovation Authority for R&D activities since 2007, with an additional 1.9 million from European authorities[152]. - The average effective tax rate for profits from Israeli operations under government benefit programs is estimated to be between 7.5% and 15%, with the standard corporate tax rate set at 23% from 2018 onwards[150]. - The company is subject to royalty payments of 3% to 5% on revenues generated from products developed with IIA funding, which are linked to the U.S. dollar[155]. - Payment of dividends may be restricted under the Companies Law, requiring profits and surplus funds criteria to be met[171]. Capital and Investment Activities - The company is currently engaged in a PIPE transaction with Fortissimo Capital, which involves an investment of 120millionfor11,650,485newlyissuedordinarysharesatapriceof120 million for 11,650,485 newly-issued ordinary shares at a price of 10.30 per share, reflecting a 10.6% premium over the market price[165]. - The company may need to raise additional capital, which could dilute existing shareholders if conducted at a lower price than their acquisition cost[165]. - Future capital requirements will depend on various factors, including the success of capturing additive manufacturing demand and costs associated with establishing sales and marketing capabilities[166]. - The company has approved a new share repurchase program in September 2024, allowing for the repurchase of up to 50millionofoutstandingordinaryshares[168].Thesharerepurchaseprogrammayreducethepublicfloatofsharesandcausevolatilityintheshareprice,withnoassuranceofapositiveimpactonsharepriceorprofitability[169].MarketPerformanceandVolatilityThemarketpriceofthecompanysordinaryshareshasfluctuatedbetween50 million of outstanding ordinary shares[168]. - The share repurchase program may reduce the public float of shares and cause volatility in the share price, with no assurance of a positive impact on share price or profitability[169]. Market Performance and Volatility - The market price of the company's ordinary shares has fluctuated between 6.16 and $54.37 from early 2020 to early 2025, indicating significant volatility[161]. - The market price of the company's ordinary shares has significantly declined, reaching all-time lows in 2024 before a slow recovery towards the end of the year[167]. Compliance and Regulatory Risks - The company may face increased liabilities if it fails to comply with the requirements of the Innovation Law, which could include penalties and mandatory repayment of grants[157]. - The company must comply with specific conditions to manufacture products and transfer technologies outside of Israel, which may increase its liabilities[152]. - The company is classified as a foreign private issuer, which allows for reduced disclosure requirements compared to domestic U.S. companies[173]. - If the company loses its foreign private issuer status, it will face increased compliance and reporting costs starting December 31, 2025[176]. - The company may be classified as a passive foreign investment company (PFIC), which could lead to adverse tax consequences for U.S. shareholders[177]. - The company does not believe it was a PFIC in 2024, but cannot assure that it will not become one in the future[178]. Dividend Policy - The company does not anticipate paying any cash dividends in the foreseeable future, meaning capital appreciation will be the sole source of return for shareholders[170].